| Add to balance / Manage account | User: | Log out |
| Prospect News home > News index > List of issuers A > Headlines for Antigenics Inc. > News item |
Antigenics to swap shares for $2 million 5.25% convertibles due 2025
By Susanna Moon
Chicago, June 9 - Antigenics Inc. agreed to issue 666,666 common shares in exchange for $2 million of its 5.25% convertible senior notes due February 2025 held by Conus Fund LP, Conus Fund Offshore Master Fund Ltd. and Conus Fund (QP) LP, according to an 8-K filing with the Securities and Exchange Commission.
The company entered into a securities exchange agreement with the holders on June 8.
Antigenics is a New York-based biotechnology company with a focus on cancers and infectious diseases.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.